Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient‐reported outcome measures

BACKGROUND: Dupilumab was equally effective among all racial subgroups in clinical trials, but a direct comparison in daily practice is lacking. OBJECTIVES: To investigate the effectiveness of dupilumab in patients with atopic dermatitis (AD) in the Netherlands and Japan over 80 weeks of treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: de Wijs, L.E.M., Fujimoto, R.F.T., Andrinopoulou, E.R., Nijsten, T., Hijnen, D., Kataoka, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453550/
https://www.ncbi.nlm.nih.gov/pubmed/33657668
http://dx.doi.org/10.1111/bjd.19897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453550/
https://www.ncbi.nlm.nih.gov/pubmed/33657668
http://dx.doi.org/10.1111/bjd.19897

Ejemplares similares